Drugs / Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02518555 | Jan 2016 → Dec 2025 | chronic lymphocytic leukemia/small lymphocytic lymphoma | Jennifer Woyach | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02518555 ↗ |
| Modality | Vaccine | “vaccine therapies” NCT02518555 ↗ |
| Route | Intramuscular | “Given IM” NCT02518555 ↗ |